News
Trade your diet soda for a tall glass of water, a new small-scale study argues. Women were more likely to drop pounds and see ...
11h
MedPage Today on MSNMifepristone Helped Control Diabetes in Those With HypercortisolismCHICAGO -- Mifepristone (Korlym) reduced HbA1c levels in patients with inadequately controlled type 2 diabetes and ...
2d
MedPage Today on MSNOnce-Weekly Basal Insulin Non-Inferior to Several Daily Options in Type 2 DiabetesA once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the phase III ...
22h
Clinical Trials Arena on MSNVertex presents data from Phase I/II stage of trial for type 1 diabetesThe safety profile of the therapy was found to be favourable, without any serious adverse events linked to the treatment.
BrightGene Pharmaceutical has scored an early win in its push to topple the big beasts of the GLP-1 field. | BrightGene ...
Now, a City of Hope study led by Geming Lu, M.D., assistant research professor, discovered that a protein called BNIP3 plays a critical role in preserving mitochondrial health and reducing the ...
Semaglutide improved time spent in glycemic range, time below rate and reduced body weight with low rates of hypoglycemia ...
CHICAGO — Actor, comedian and diabetes advocate Anthony Anderson has lived with diabetes for almost 25 years, and has made ...
Special Call (Lilly Investor Event at American Diabetes Association's (ADA) 85th Scientific Sessions) Conference June ...
Diabetes pills could hit Australian shelves within years, offering an alternative to popular injectable treatments such as ...
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results